New & Noteworthy

Submit New & Noteworthy

March 2021

Generic Abiraterone Acetate Tablets, USP, 500 mg

Amneal Pharmaceuticals

Amneal Pharmaceuticals releases abiraterone acetate tablets, USP, 250 mg and 500 mg following FDA approval of Amneal’s Abbreviated New Drug Application (ANDA), approved for its use in combination with prednisone. Abiraterone acetate tablets, USP, 250 mg, and 500 mg, are the generic version of Zytiga for the treatment of metastatic prostate cancer. Following approval of the additional 500 mg strength, Amneal has increased commercialization to increase access.

Amneal Pharmaceuticals, Inc

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: